Skip to content


  • Add this article to your LinkedIn page
  • Add this article to your Twitter feed
  • Add this article to your Facebook page
  • Email this article
  • View or print a PDF of this page
  • Share further
  • Add this article to your Pinterest board
  • Add this article to your Google page
  • Share this article on Reddit
  • Share this article on StumbleUpon
  • Bookmark this page

Global chemicals group: Finding a new role in pharmaceuticals

Among other capabilities a global Fortune 500 group produces ingredients for dietary supplements and food and drink products. This business unit has been very successful, expanding at double digit growth rates and delivering strong profitability. The group believed they could build on this success by creating a new venture to develop pharmaceutical grade ingredients.

Our strategy experts helped the group:

  • pinpoint the best applications, narrowing them down from over 70 to eight, including those focused on metabolic and cardiovascular conditions
  • determine the product format and business model
  • find out which capabilities they’d need to develop to be able to operate in this new way
  • partner with other groups to sponsor the research that will lead to new IP.

The work now means the board is behind the effort to stake out new ground in pharmaceuticals. The company is investing tens of €millions in its programme to find the right research partners and carry out its own R&D.

Contact the strategy team


By using this website, you accept the use of cookies. For more information on how to manage cookies, please read our privacy policy.